STIM1 and breast cancer: Diminishing SOCE via STIM1 inhibited the proliferation of cervical cancer, glioblastoma (U251), osteosarcoma (143B and U2OS), lung carcinoma (A549 and SK-MES-1), and breast cancer (MCF7) [265,266,267,268,269,270,271,272].